APO Research

APO RESEARCH · REPORT

Peripheral Liquid Embolic Agents

Selected research

Industry Growth & Trends

Global Peripheral Liquid Embolic Agents Industry Growth and Trends Forecast to 2032

Market perspective

The global Peripheral Liquid Embolic Agents market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Peripheral Liquid Embolic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Peripheral Liquid Embolic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Peripheral Liquid Embolic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Peripheral Liquid Embolic Agents include Grand Pharmaceutical Group, Olympus and Medtronic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Peripheral Liquid Embolic Agents market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Peripheral Liquid Embolic Agents market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Peripheral Liquid Embolic Agents market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Peripheral Liquid Embolic Agents.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Peripheral Liquid Embolic Agents market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Peripheral Liquid Embolic Agents Market by Company

Grand Pharmaceutical Group

Olympus

Medtronic

Peripheral Liquid Embolic Agents Segment by Type

Tube Applicators

Tympanostomy Tubes

Peripheral Liquid Embolic Agents Segment by Application

Hospital

Clinic

Others

Peripheral Liquid Embolic Agents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peripheral Liquid Embolic Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peripheral Liquid Embolic Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peripheral Liquid Embolic Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Peripheral Liquid Embolic Agents manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Peripheral Liquid Embolic Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tube Applicators Table 2. Major Company of Tympanostomy Tubes Table 3. Global Peripheral Liquid Embolic Agents Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Peripheral Liquid Embolic Agents Sales by Type (2021-2026) & (K Units) Table 5. Global Peripheral Liquid Embolic Agents Sales Market Share in Volume by Type (2021-2026) Table 6. Global Peripheral Liquid Embolic Agents Sales by Type (2021-2026) & (US$ Million) Table 7. Global Peripheral Liquid Embolic Agents Sales Market Share in Value by Type (2021-2026) Table 8. Global Peripheral Liquid Embolic Agents Price by Type (2021-2026) & (US$/Unit) Table 9. Global Peripheral Liquid Embolic Agents Sales by Type (2027-2032) & (K Units) Table 10. Global Peripheral Liquid Embolic Agents Sales Market Share in Volume by Type (2027-2032) Table 11. Global Peripheral Liquid Embolic Agents Sales by Type (2027-2032) & (US$ Million) Table 12. Global Peripheral Liquid Embolic Agents Sales Market Share in Value by Type (2027-2032) Table 13. Global Peripheral Liquid Embolic Agents Price by Type (2027-2032) & (US$/Unit) Table 14. North America Peripheral Liquid Embolic Agents Sales by Type (2021-2026) & (K Units) Table 15. North America Peripheral Liquid Embolic Agents Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Peripheral Liquid Embolic Agents Sales by Type (2021-2026) & (K Units) Table 17. Europe Peripheral Liquid Embolic Agents Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Peripheral Liquid Embolic Agents Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Peripheral Liquid Embolic Agents Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Peripheral Liquid Embolic Agents Sales by Type (2021-2026) & (K Units) Table 21. Latin America Peripheral Liquid Embolic Agents Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Peripheral Liquid Embolic Agents Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Peripheral Liquid Embolic Agents Sales by Type (2021-2026) & (US$ Million) Table 24. Peripheral Liquid Embolic Agents Industry Trends Table 25. Peripheral Liquid Embolic Agents Industry Drivers Table 26. Peripheral Liquid Embolic Agents Industry Opportunities and Challenges Table 27. Peripheral Liquid Embolic Agents Industry Restraints Table 28. Global Peripheral Liquid Embolic Agents Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Peripheral Liquid Embolic Agents Revenue Market Share by Company (2021-2026) Table 30. Global Peripheral Liquid Embolic Agents Sales by Company (2021-2026) & (K Units) Table 31. Global Peripheral Liquid Embolic Agents Sales Share by Company (2021-2026) Table 32. Global Peripheral Liquid Embolic Agents Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Peripheral Liquid Embolic Agents Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Peripheral Liquid Embolic Agents Major Company Production Sites and Headquarters Table 35. Global Peripheral Liquid Embolic Agents Company, Product Type & Application Table 36. Global Peripheral Liquid Embolic Agents Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Peripheral Liquid Embolic Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Peripheral Liquid Embolic Agents Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Peripheral Liquid Embolic Agents Sales by Region (2021-2026) & (K Units) Table 41. Global Peripheral Liquid Embolic Agents Sales Market Share in Volume by Region (2021-2026) Table 42. Global Peripheral Liquid Embolic Agents Sales by Region (2021-2026) & (US$ Million) Table 43. Global Peripheral Liquid Embolic Agents Sales Market Share in Value by Region (2021-2026) Table 44. Global Peripheral Liquid Embolic Agents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Peripheral Liquid Embolic Agents Sales by Region (2027-2032) & (K Units) Table 46. Global Peripheral Liquid Embolic Agents Sales Market Share in Volume by Region (2027-2032) Table 47. Global Peripheral Liquid Embolic Agents Sales by Region (2027-2032) & (US$ Million) Table 48. Global Peripheral Liquid Embolic Agents Sales Market Share in Value by Region (2027-2032) Table 49. Global Peripheral Liquid Embolic Agents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Peripheral Liquid Embolic Agents Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Peripheral Liquid Embolic Agents Sales by Application (2021-2026) & (K Units) Table 52. Global Peripheral Liquid Embolic Agents Sales Market Share in Volume by Application (2021-2026) Table 53. Global Peripheral Liquid Embolic Agents Sales by Application (2021-2026) & (US$ Million) Table 54. Global Peripheral Liquid Embolic Agents Sales Market Share in Value by Application (2021-2026) Table 55. Global Peripheral Liquid Embolic Agents Price by Application (2021-2026) & (US$/Unit) Table 56. Global Peripheral Liquid Embolic Agents Sales by Application (2027-2032) & (K Units) Table 57. Global Peripheral Liquid Embolic Agents Sales Market Share in Volume by Application (2027-2032) Table 58. Global Peripheral Liquid Embolic Agents Sales by Application (2027-2032) & (US$ Million) Table 59. Global Peripheral Liquid Embolic Agents Sales Market Share in Value by Application (2027-2032) Table 60. Global Peripheral Liquid Embolic Agents Price by Application (2027-2032) & (US$/Unit) Table 61. North America Peripheral Liquid Embolic Agents Sales by Application (2021-2026) & (K Units) Table 62. North America Peripheral Liquid Embolic Agents Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Peripheral Liquid Embolic Agents Sales by Application (2021-2026) & (K Units) Table 64. Europe Peripheral Liquid Embolic Agents Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Peripheral Liquid Embolic Agents Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Peripheral Liquid Embolic Agents Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Peripheral Liquid Embolic Agents Sales by Application (2021-2026) & (K Units) Table 68. Latin America Peripheral Liquid Embolic Agents Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Peripheral Liquid Embolic Agents Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Peripheral Liquid Embolic Agents Sales by Application (2021-2026) & (US$ Million) Table 71. Grand Pharmaceutical Group Company Information Table 72. Grand Pharmaceutical Group Business Overview Table 73. Grand Pharmaceutical Group Peripheral Liquid Embolic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Grand Pharmaceutical Group Peripheral Liquid Embolic Agents Product Portfolio Table 75. Grand Pharmaceutical Group Recent Development Table 76. Olympus Company Information Table 77. Olympus Business Overview Table 78. Olympus Peripheral Liquid Embolic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Olympus Peripheral Liquid Embolic Agents Product Portfolio Table 80. Olympus Recent Development Table 81. Medtronic Company Information Table 82. Medtronic Business Overview Table 83. Medtronic Peripheral Liquid Embolic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Medtronic Peripheral Liquid Embolic Agents Product Portfolio Table 85. Medtronic Recent Development Table 86. North America Peripheral Liquid Embolic Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 87. North America Peripheral Liquid Embolic Agents Sales by Country (2021-2026) & (K Units) Table 88. North America Peripheral Liquid Embolic Agents Sales Market Share by Country (2021-2026) Table 89. North America Peripheral Liquid Embolic Agents Sales Forecast by Country (2027-2032) & (K Units) Table 90. North America Peripheral Liquid Embolic Agents Sales Market Share Forecast by Country (2027-2032) Table 91. North America Peripheral Liquid Embolic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. North America Peripheral Liquid Embolic Agents Market Size by Country (2021-2026) & (US$ Million) Table 93. North America Peripheral Liquid Embolic Agents Market Share by Country (2021-2026) Table 94. North America Peripheral Liquid Embolic Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. North America Peripheral Liquid Embolic Agents Market Share Forecast by Country (2027-2032) Table 96. Europe Peripheral Liquid Embolic Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 97. Europe Peripheral Liquid Embolic Agents Sales by Country (2021-2026) & (K Units) Table 98. Europe Peripheral Liquid Embolic Agents Sales Market Share by Country (2021-2026) Table 99. Europe Peripheral Liquid Embolic Agents Sales Forecast by Country (2027-2032) & (K Units) Table 100. Europe Peripheral Liquid Embolic Agents Sales Market Share Forecast by Country (2027-2032) Table 101. Europe Peripheral Liquid Embolic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Europe Peripheral Liquid Embolic Agents Market Size by Country (2021-2026) & (US$ Million) Table 103. Europe Peripheral Liquid Embolic Agents Market Share by Country (2021-2026) Table 104. Europe Peripheral Liquid Embolic Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Europe Peripheral Liquid Embolic Agents Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Peripheral Liquid Embolic Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Peripheral Liquid Embolic Agents Sales by Country (2021-2026) & (K Units) Table 108. Asia-Pacific Peripheral Liquid Embolic Agents Sales Market Share by Country (2021-2026) Table 109. Asia-Pacific Peripheral Liquid Embolic Agents Sales Forecast by Country (2027-2032) & (K Units) Table 110. Asia-Pacific Peripheral Liquid Embolic Agents Sales Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Peripheral Liquid Embolic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Peripheral Liquid Embolic Agents Market Size by Country (2021-2026) & (US$ Million) Table 113. Asia-Pacific Peripheral Liquid Embolic Agents Market Share by Country (2021-2026) Table 114. Asia-Pacific Peripheral Liquid Embolic Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Asia-Pacific Peripheral Liquid Embolic Agents Market Share Forecast by Country (2027-2032) Table 116. Latin America Peripheral Liquid Embolic Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Latin America Peripheral Liquid Embolic Agents Sales by Country (2021-2026) & (K Units) Table 118. Latin America Peripheral Liquid Embolic Agents Sales Market Share by Country (2021-2026) Table 119. Latin America Peripheral Liquid Embolic Agents Sales Forecast by Country (2027-2032) & (K Units) Table 120. Latin America Peripheral Liquid Embolic Agents Sales Market Share Forecast by Country (2027-2032) Table 121. Latin America Peripheral Liquid Embolic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Latin America Peripheral Liquid Embolic Agents Market Size by Country (2021-2026) & (US$ Million) Table 123. Latin America Peripheral Liquid Embolic Agents Market Share by Country (2021-2026) Table 124. Latin America Peripheral Liquid Embolic Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Latin America Peripheral Liquid Embolic Agents Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Peripheral Liquid Embolic Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Peripheral Liquid Embolic Agents Sales by Country (2021-2026) & (K Units) Table 128. Middle East and Africa Peripheral Liquid Embolic Agents Sales Market Share by Country (2021-2026) Table 129. Middle East and Africa Peripheral Liquid Embolic Agents Sales Forecast by Country (2027-2032) & (K Units) Table 130. Middle East and Africa Peripheral Liquid Embolic Agents Sales Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Peripheral Liquid Embolic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Peripheral Liquid Embolic Agents Market Size by Country (2021-2026) & (US$ Million) Table 133. Middle East and Africa Peripheral Liquid Embolic Agents Market Share by Country (2021-2026) Table 134. Middle East and Africa Peripheral Liquid Embolic Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Middle East and Africa Peripheral Liquid Embolic Agents Market Share Forecast by Country (2027-2032) Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Peripheral Liquid Embolic Agents Distributors List Table 139. Peripheral Liquid Embolic Agents Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Peripheral Liquid Embolic Agents Image Figure 2. Global Peripheral Liquid Embolic Agents Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Peripheral Liquid Embolic Agents Market Size (2021-2032) & (US$ Million) Figure 4. Global Peripheral Liquid Embolic Agents Sales (2021-2032) & (K Units) Figure 5. Tube Applicators Image Figure 6. Global Tube Applicators Sales YoY Growth (2021-2032) & (K Units) Figure 7. Tympanostomy Tubes Image Figure 8. Global Tympanostomy Tubes Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Peripheral Liquid Embolic Agents Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Peripheral Liquid Embolic Agents Market Share by Type 2025 VS 2032 Figure 11. North America Peripheral Liquid Embolic Agents Sales Market Share in Volume by Type in 2025 Figure 12. North America Peripheral Liquid Embolic Agents Sales Market Share in Value by Type in 2025 Figure 13. Europe Peripheral Liquid Embolic Agents Sales Market Share in Volume by Type in 2025 Figure 14. Europe Peripheral Liquid Embolic Agents Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Peripheral Liquid Embolic Agents Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Peripheral Liquid Embolic Agents Sales Market Share in Value by Type in 2025 Figure 17. Latin America Peripheral Liquid Embolic Agents Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Peripheral Liquid Embolic Agents Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Peripheral Liquid Embolic Agents Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Peripheral Liquid Embolic Agents Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Peripheral Liquid Embolic Agents Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Peripheral Liquid Embolic Agents Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Peripheral Liquid Embolic Agents Market Share by Application 2025 VS 2032 Figure 31. North America Peripheral Liquid Embolic Agents Sales Market Share in Volume by Application in 2025 Figure 32. North America Peripheral Liquid Embolic Agents Sales Market Share in Value by Application in 2025 Figure 33. Europe Peripheral Liquid Embolic Agents Sales Market Share in Volume by Application in 2025 Figure 34. Europe Peripheral Liquid Embolic Agents Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Peripheral Liquid Embolic Agents Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Peripheral Liquid Embolic Agents Sales Market Share in Value by Application in 2025 Figure 37. Latin America Peripheral Liquid Embolic Agents Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Peripheral Liquid Embolic Agents Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Peripheral Liquid Embolic Agents Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Peripheral Liquid Embolic Agents Sales Market Share in Value by Application in 2025 Figure 41. North America Peripheral Liquid Embolic Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Peripheral Liquid Embolic Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Peripheral Liquid Embolic Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Peripheral Liquid Embolic Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Peripheral Liquid Embolic Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Peripheral Liquid Embolic Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Peripheral Liquid Embolic Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Peripheral Liquid Embolic Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Peripheral Liquid Embolic Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Peripheral Liquid Embolic Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Peripheral Liquid Embolic Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Peripheral Liquid Embolic Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Peripheral Liquid Embolic Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Peripheral Liquid Embolic Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Peripheral Liquid Embolic Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Peripheral Liquid Embolic Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Peripheral Liquid Embolic Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Peripheral Liquid Embolic Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Peripheral Liquid Embolic Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Peripheral Liquid Embolic Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Peripheral Liquid Embolic Agents Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Peripheral Liquid Embolic Agents Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Tube Applicators
  • Tympanostomy Tubes
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Grand Pharmaceutical Group
  • Olympus
  • Medtronic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Peripheral Liquid Embolic Agents Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Peripheral Liquid Embolic Agents Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Peripheral Liquid Embolic Agents Market by Type
  6. 1.3.1 Tube Applicators
  7. 1.3.2 Tympanostomy Tubes
  8. 1.4 Global Peripheral Liquid Embolic Agents Market Size by Type
  9. 1.4.1 Global Peripheral Liquid Embolic Agents Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Peripheral Liquid Embolic Agents Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Peripheral Liquid Embolic Agents Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Peripheral Liquid Embolic Agents Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Peripheral Liquid Embolic Agents Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Peripheral Liquid Embolic Agents Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Peripheral Liquid Embolic Agents Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Peripheral Liquid Embolic Agents Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Peripheral Liquid Embolic Agents Industry Trends
  2. 2.2 Peripheral Liquid Embolic Agents Industry Drivers
  3. 2.3 Peripheral Liquid Embolic Agents Industry Opportunities and Challenges
  4. 2.4 Peripheral Liquid Embolic Agents Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Peripheral Liquid Embolic Agents Revenue (2021-2026)
  2. 3.2 Global Top Players by Peripheral Liquid Embolic Agents Sales (2021-2026)
  3. 3.3 Global Top Players by Peripheral Liquid Embolic Agents Price (2021-2026)
  4. 3.4 Global Peripheral Liquid Embolic Agents Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Peripheral Liquid Embolic Agents Major Company Production Sites & Headquarters
  6. 3.6 Global Peripheral Liquid Embolic Agents Company, Product Type & Application
  7. 3.7 Global Peripheral Liquid Embolic Agents Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Peripheral Liquid Embolic Agents Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Peripheral Liquid Embolic Agents Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Peripheral Liquid Embolic Agents Tier 1, Tier 2, and Tier 3
4 Peripheral Liquid Embolic Agents Regional Status and Outlook
  1. 4.1 Global Peripheral Liquid Embolic Agents Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Peripheral Liquid Embolic Agents Historic Market Size by Region
  3. 4.2.1 Global Peripheral Liquid Embolic Agents Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Peripheral Liquid Embolic Agents Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Peripheral Liquid Embolic Agents Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Peripheral Liquid Embolic Agents Forecasted Market Size by Region
  7. 4.3.1 Global Peripheral Liquid Embolic Agents Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Peripheral Liquid Embolic Agents Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Peripheral Liquid Embolic Agents Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Peripheral Liquid Embolic Agents by Application
  1. 5.1 Peripheral Liquid Embolic Agents Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Peripheral Liquid Embolic Agents Market Size by Application
  6. 5.2.1 Global Peripheral Liquid Embolic Agents Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Peripheral Liquid Embolic Agents Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Peripheral Liquid Embolic Agents Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Peripheral Liquid Embolic Agents Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Peripheral Liquid Embolic Agents Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Peripheral Liquid Embolic Agents Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Peripheral Liquid Embolic Agents Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Peripheral Liquid Embolic Agents Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Grand Pharmaceutical Group
  2. 6.1.1 Grand Pharmaceutical Group Company Information
  3. 6.1.2 Grand Pharmaceutical Group Business Overview
  4. 6.1.3 Grand Pharmaceutical Group Peripheral Liquid Embolic Agents Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Grand Pharmaceutical Group Peripheral Liquid Embolic Agents Product Portfolio
  6. 6.1.5 Grand Pharmaceutical Group Recent Developments
  7. 6.2 Olympus
  8. 6.2.1 Olympus Company Information
  9. 6.2.2 Olympus Business Overview
  10. 6.2.3 Olympus Peripheral Liquid Embolic Agents Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Olympus Peripheral Liquid Embolic Agents Product Portfolio
  12. 6.2.5 Olympus Recent Developments
  13. 6.3 Medtronic
  14. 6.3.1 Medtronic Company Information
  15. 6.3.2 Medtronic Business Overview
  16. 6.3.3 Medtronic Peripheral Liquid Embolic Agents Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Medtronic Peripheral Liquid Embolic Agents Product Portfolio
  18. 6.3.5 Medtronic Recent Developments
7 North America by Country
  1. 7.1 North America Peripheral Liquid Embolic Agents Sales by Country
  2. 7.1.1 North America Peripheral Liquid Embolic Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Peripheral Liquid Embolic Agents Sales by Country (2021-2026)
  4. 7.1.3 North America Peripheral Liquid Embolic Agents Sales Forecast by Country (2027-2032)
  5. 7.2 North America Peripheral Liquid Embolic Agents Market Size by Country
  6. 7.2.1 North America Peripheral Liquid Embolic Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Peripheral Liquid Embolic Agents Market Size by Country (2021-2026)
  8. 7.2.3 North America Peripheral Liquid Embolic Agents Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Peripheral Liquid Embolic Agents Sales by Country
  2. 8.1.1 Europe Peripheral Liquid Embolic Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Peripheral Liquid Embolic Agents Sales by Country (2021-2026)
  4. 8.1.3 Europe Peripheral Liquid Embolic Agents Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Peripheral Liquid Embolic Agents Market Size by Country
  6. 8.2.1 Europe Peripheral Liquid Embolic Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Peripheral Liquid Embolic Agents Market Size by Country (2021-2026)
  8. 8.2.3 Europe Peripheral Liquid Embolic Agents Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Peripheral Liquid Embolic Agents Sales by Country
  2. 9.1.1 Asia-Pacific Peripheral Liquid Embolic Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Peripheral Liquid Embolic Agents Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Peripheral Liquid Embolic Agents Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Peripheral Liquid Embolic Agents Market Size by Country
  6. 9.2.1 Asia-Pacific Peripheral Liquid Embolic Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Peripheral Liquid Embolic Agents Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Peripheral Liquid Embolic Agents Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Peripheral Liquid Embolic Agents Sales by Country
  2. 10.1.1 South America Peripheral Liquid Embolic Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Peripheral Liquid Embolic Agents Sales by Country (2021-2026)
  4. 10.1.3 South America Peripheral Liquid Embolic Agents Sales Forecast by Country (2027-2032)
  5. 10.2 South America Peripheral Liquid Embolic Agents Market Size by Country
  6. 10.2.1 South America Peripheral Liquid Embolic Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Peripheral Liquid Embolic Agents Market Size by Country (2021-2026)
  8. 10.2.3 South America Peripheral Liquid Embolic Agents Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Peripheral Liquid Embolic Agents Sales by Country
  2. 11.1.1 Middle East and Africa Peripheral Liquid Embolic Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Peripheral Liquid Embolic Agents Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Peripheral Liquid Embolic Agents Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Peripheral Liquid Embolic Agents Market Size by Country
  6. 11.2.1 Middle East and Africa Peripheral Liquid Embolic Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Peripheral Liquid Embolic Agents Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Peripheral Liquid Embolic Agents Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Peripheral Liquid Embolic Agents Value Chain Analysis
  2. 12.1.1 Peripheral Liquid Embolic Agents Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Peripheral Liquid Embolic Agents Production Mode & Process
  7. 12.2 Peripheral Liquid Embolic Agents Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Peripheral Liquid Embolic Agents Distributors
  10. 12.2.3 Peripheral Liquid Embolic Agents Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research